Quantitative trait loci associated with elevated thyroid-stimulating hormone in the Wistar-Kyoto rat

Endocrinology

Volumn 146, Issue 2, 2005, Pages 870-878

  Baum, Amber E ^a   Solberg, Leah C ^a,b   Kopp, Peter ^a   Ahmadiyeh, Nasim ^a,b   Churchill, Gary ^c   Takahashi, Joseph S ^b   Jameson, J Larry ^a   Redei, Eva E ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; THYROTROPIN; THYROXINE;

ALLELE; ANIMAL EXPERIMENT; ARTICLE; CHROMOSOME 5; CHROMOSOME 6; CONFIDENCE INTERVAL; CONTROLLED STUDY; GENE SEQUENCE; GENETIC REGULATION; GENETIC VARIABILITY; HORMONE RELEASE; HYPERTHYROIDISM; INBRED STRAIN; LIOTHYRONINE BLOOD LEVEL; MALE; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; RAT; RAT STRAIN; REGULATORY MECHANISM; SEQUENCE HOMOLOGY; STRAIN DIFFERENCE; THYROID FUNCTION; THYROID FUNCTION TEST; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

3' UNTRANSLATED REGIONS; ANIMALS; CIRCADIAN RHYTHM; FEMALE; GENOME; IODIDE PEROXIDASE; MALE; NERVE TISSUE PROTEINS; QUANTITATIVE TRAIT LOCI; RATS; RATS, INBRED F344; RATS, INBRED WKY; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 12344276455     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2004-0948     Document Type: Article

References (39)

1. Samollow PB, Ferez G, Kammerer CM, Finegold D, Zwartjes PW, Havill LM, Comuzzie AG, Mahaney MC, Goring HH, Blangero J, Foley TP, Barmada MM 2004 Genetic and environmental influences on thyroid hormone variation in Mexican Americans. J Clin Endocrinol Metab 89:3276-3284
2. Peeters RP, van Toor H, Klootwijk W, de Rijke YB, Kuiper GG, Uitterlinden AG, Visser TJ 2003 Polymorphisms in thyroid hormone pathway genes are associated with plasma TSH and iodothyronine levels in healthy subjects. J Clin Endocrinol Metab 88:2880-2888
3. Harper JM, Galecki AT, Burke DT, Pinkosky SL, Miller RA 2003 Quantitative trait loci for insulin-like growth factor I, leptin, thyroxine, and corticosterone in genetically heterogeneous mice. Physiol Genomics 15:44-51
4. Pare W, Redei E 1995 A biobehavioral profile of an ulcer susceptible rat strain. In: Szabo S, Tache Y, eds. Neuroendocrinology of gastrointestinal ulceration. New York: Plenum Press; 201-208
5. Redei EE, Solberg LC, Kluczynski JM, Pare WP 2001 Paradoxical hormonal and behavioral responses to hypothyroid and hyperthyroid states in the Wistar Kyoto rat. Neuropsychopharmacology 24:632-639
6. Solberg LC, Losee-Olsen S, Turek FW, Redei E 2001 Altered hormonal secretions and circadian rhythm of activity in the Wistar Kyoto rat, a putative animal model of depression. Am J Physiol 281:R786-R794
7. Suzuki S, Solberg LC, Redei EE, Handa RJ 2001 Prepro-thyrotropin releasing hormone 178-199 immunoreactivity is altered in the hypothalamus of the Wistar-Kyoto strain of rat. Brain Res 913:224-233
8. Li QL, Jansen E, Brent GA, Naqvi S, Wilber JF, Friedman TC 2000 Interactions between the prohormone convertase 2 promoter and the thyroid hormone receptor. Endocrinology 141:3256-3266
9. Redei E, Pare WP, Aird F, Kluczynski J 1994 Strain differences in hypothalamic-pituitary-adrenal activity and stress ulcer. Am J Physiol 266:R353-R360
10. Abiola O, Angel JM, Avner P, Bachmanov AA, Belknap JK, Bennett B, Blankenhom EP, Blizard DA, Bolivar V, Brockmann GA, Buck KJ, Bureau JF, Casley WL, Chesler EJ, Cheverud JM, Churchill GA, Cook M, Crabbe JC, Crusio WE, Darvasi A, de Haan G, Dermant P, Doerge RW, Elliot RW, Farber CR, et al. 2003 The nature and identification of quantitative trait loci: a community's view. Nat Rev Genet 4:911-916
11. Rittenhouse PA, Redei E 1997 Thyroxine administration prevents streptococcal cell wall-induced inflammatory responses. Endocrinology 138:1434-1439
12. De Souza EB, Van Loon GR 1989 Rate-sensitive glucocorticoid feedback inhibition of adrenocorticotropin and B-endorphin/B-lipotropin secretion in rats. Endocrinology 125:2927-2934
13. Jones MT, Brush FR, Neame RL 1972 Characteristics of fast feedback control of corticotrophin release by corticosteroids. J Endocrinol 55:489-497
14. Shimomura K, Low-Zeddies SS, King DP, Sleeves TD, Whiteley A, Kushla J, Zemenides PD, Lin A, Vitatema MH, Churchill GA, Takahashi JS 2001 Genome-wide epistatic interaction analysis reveals complex genetic determinants of circadian behavior in mice. Genome Res 11:959-980
15. Broman KW, Wu H, Sen S, Churchill GA 2003 R/qtl: QTL mapping in experimental crosses. Bioinformatics 19:889-890
16. Churchill GA, Doerge RW 1994 Empirical threshold values for quantitative trait mapping. Genetics 138:963-971
17. Lander E, Kruglyak L1995 Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 11:241-247
18. Ahmadiyeh N, Churchill GA, Shimomura K, Solberg LC, Takahashi JS, Redei EE 2003 X-linked and lineage-dependent inheritance of coping responses to stress. Mamm Genome 14:748-757
19. Sugiyama F, Churchill GA, Li R, Libby LJ, Carver T, Yagami K, John SW, Paigen B 2002 QTL associated with blood pressure, heart rate, and heart weight in CBA/CaJ and BALB/cJ mice. Physiol Genom 10:5-12
20. Sen S, Churchill GA 2001 A statistical framework for quantitative trait mapping. Genetics 159:371-387
21. Solberg LC, Baum AE, Ahmadiyeh N, Churchill GA, Shimomura K, Li R, Turek FW, Takahashi JS, Redei EE 2004 Sex- and lineage-specific inheritance of depressive-like behavior in the rat. Mamm Genome 15:648-662
22. Graters A, Schoneberg T, Biebermann H, Krade H, Krohn HP, Dralle H, Gudermann T1998 Severe congenital hyperthyroidism caused by a germ-line neo mutation in the extracellular portion of the thyrotropin receptor. J Clin Endocrinol Metab 83:1431-1436
23. Wonerow P, Neumann S, Gudermann T, Paschke R 2001 Thyrotropin receptor mutations as a tool to understand thyrotropin receptor action. J Mol Med 79:707-721
24. Kopp P 2001 The TSH receptor and its role in thyroid disease. Cell Mol Life Sci 58:1301-1322
25. Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR 2002 Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 23:38-89
26. Mendell JT, Dietz HC 2001 When the message goes awry: disease-producing mutations that influence mRNA content and performance. Cell 107:411-414
27. Lescure A, Gautheret D, Carbon P, Krol A 1999 Novel selenoproteins identified in silico and in vivo by using a conserved RNA structural motif. J Biol Chem 274:38147-38154
28. Nowak FV 1990 Cloning of two hypothalamic cDNAs encoding tissue-specific transcripts in the preoptic area and testis. Mol Endocrinol 4:1205-1210
29. Nowak FV 2003 Expression and characterization of the preoptic regulatory factor-1 and -2 peptides. Regul Pept 115:179-185
30. Refetoff S 2003 Resistance to thyrotropin. J Endocrinol Invest 26:770-779
31. Hamann A, Disque C, Munzberg H, Tafel J, Hinney A, Mayer H, Hebebrand J, Ziegler R 2001 Mutational screening of the human type II deiodinase gene. Horm Metab Res 33:508-509
32. Mentuccia D, Proietti-Pannunzi L, Tanner K, Bacci V, Pollin TL Poehlman ET, Shuldiner AR, Celi FS 2002 Association between a novel variant of the human type 2 deiodinase gene Thr92Ala and insulin resistance: evidence of interaction with the Trp64Arg variant of the β-3-adrenergic receptor. Diabetes 51:880-883
33. Martin 3rd GW, Hamey JW, Berry MJ 1998 Functionality of mutations at conserved nucleotides in eukaryotic SECIS elements is determined by the identity of a single nonconserved nucleotide. RNA 4:65-73
34. Gereben B, Kollar A, Hamey JW, Larsen PR 2002 The mRNA structure has potent regulatory effects on type 2 iodothyronine deiodinase expression. Mol Endocrinol 16:1667-1679
35. Refetoff S, Weiss RE, Usala SJ 1993 The syndromes of resistance to thyroid hormone. Endocr Rev 14:348-399
36. Persani L1998 Hypothalamic thyrotropin-releasing hormone and thyrotropin biological activity. Thyroid 8:941-946
37. Yamada M, Saga Y, Shibusawa N, Hirato J, Murakami M, Iwasaki T, Hashimoto K, Satoh T, Wakabayashi K, Taketo MM, Mon M 1997 Tertiary hypothyroidism and hyperglycemia in mice with targeted disruption of the thyrotropin-releasing hormone gene. Proc Natl Acad Sci USA 94:10862-10867
38. Medeiros-Neto G, Herodotou DT, Rajan S, Kommareddi S, de Lacerda L, Sandrini R, Boguszewski MC, Hollenberg AN, Radovick S, Wondisford FE 1996 A circulating, biologically inactive thyrotropin caused by a mutation in the β-subunit gene. J Clin Invest 97:1250-1256
39. 4. Mol Endocrinol 15:2137-2148